Skip to main navigation
MoonLake MoonLake
e: info@moonlaketx.com
  • About us
    • About MoonLake TX
    • Careers
    • Team
  • Science
    • The science
    • Therapeutic focus
    • Pipeline
  • Investor relations
    • Investors overview
    • Stock information
    • Press releases
    • Events & presentations
    • Corporate governance
    • Financials & filings
    • Email alerts
Site - Main
  • About us
    • About MoonLake TX
    • Careers
    • Team
  • Science
    • The science
    • Therapeutic focus
    • Pipeline
  • Investor relations
    • Investors overview
    • Stock information
    • Press releases
    • Events & presentations
    • Corporate governance
    • Financials & filings
    • Email alerts
e: info@moonlaketx.com

INVESTOR RELATIONS

IR Overview

Stock Information



Data Provided by Refinitiv. Minimum 15 minutes delayed.

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
View Stock Information +

IR contact details

Roman Akbar-Haase
Director Investor Relations and Business Development

e: ir@moonlaketx.com

Upcoming events
Apr 15 - Apr 16 2026
Van Lanschot Kempen Life Sciences Conference, Amsterdam, Netherlands
May 19 - May 20 2026
RBC Capital Markets Global Healthcare Conference, New York City, NY
Jun 3 - Jun 6 2026
EULAR (European Alliance of Associations for Rheumatology) congress, London, UK

View All Events

View All Events +
Corporate presentations
MoonLake Investor Day (Feb 2026)
Clinical Data Update (Nov 2025)

View All Presentations

View All Presentations +
Latest press releases
Mar 28 2026
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Feb 22 2026
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Feb 02 2026
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

View All News

View All Press Releases +
Site - Investor Tools
Print Page
RSS Feeds
Email Alerts
Contact IR

Contact Us

MoonLake Immunotherapeutics Dorfstrasse 29, 6300 Zug, Schweiz/Switzerland
e: info@moonlaketx.com 
media: media@moonlaketx.com 
IR: ir@moonlaketx.com
 
LinkedIn 

Quick Links

  • Home
  • About us
  • Team
  • Science
  • Pipeline
  • Therapeutic focus
  • Investor relations
  • Careers
  • Privacy policy

© 2026 -  MoonLake Immunotherapeutics

Privacy Policy